QPPV.COM KNOWLEDGE ASSESSMENT

Knowledge Assessment: Writing the PSUR Safety Evaluation

Test your understanding of the concepts covered by GVP Module VII: Writing the PSUR Safety Evaluation.

Question 1 of 10Pass mark: 80%

Question 1 of 10 Spontaneous reports suggest an association, but observational studies do not show increased risk. What should the PSUR evaluation do?

Average the findings and report an intermediate conclusion Select the source with the largest sample without further analysis Investigate differences in populations, exposure definitions, confounding, outcome ascertainment, comparator choice, and statistical power Treat the observational studies as proof that the reports are unrelated

Question 2 of 10 What should a strong PSUR conclusion normally communicate?

Only whether a new signal was validated What was found, what it means, how certain the assessment is, and what should happen next Only the preferred regulatory action A single overall numerical estimate of benefit-risk

Question 3 of 10 A potential signal remains under evaluation at the time of PSUR preparation. Which wording is most scientifically appropriate?

The event is an established new risk The event is disproven because no regulatory action has yet occurred The available evidence and limitations are described, while the association remains under evaluation The event should be excluded until the signal is validated

Question 4 of 10 Which governance issue is most directly illustrated when the PSUR says 'no change' despite new information discussed elsewhere in the report?

The report contains too many clinical narratives The integrated benefit-risk rationale is not adequately connected to the evidence The product has insufficient exposure data by definition The PSUR has used too many subgroup analyses

Question 5 of 10 Why should exposure be examined when report counts increase?

Because report counts are meaningful only for products with stable exposure Because an increase in exposure may explain more reports without indicating a higher underlying event rate Because exposure estimates establish causality by themselves Because exposure is relevant only to clinical trial data

Question 6 of 10 What does proportionate evaluation of individual safety concerns mean?

Only confirmed risks require any analysis Every issue must receive identical analytical depth The depth of analysis should reflect potential seriousness, clinical relevance, novelty, evidence strength, affected population, preventability, and possible benefit-risk impact Analysis should focus exclusively on the issue with the greatest number of reports

Question 7 of 10 What is the principal purpose of considering medical need and treatment alternatives in a PSUR?

To justify disregarding serious adverse reactions To replace assessment of the product's risks with an economic analysis To provide clinical context for understanding the significance of risks relative to expected therapeutic benefit and available options To establish that products with no alternatives are exempt from risk minimisation

Question 8 of 10 A known hepatic adverse reaction has increased from 310 to 420 reports in the reporting interval. Which is the most appropriate initial interpretation?

The underlying risk has increased by approximately 35% The increase establishes a new safety signal The increase requires evaluation of exposure, reporting patterns, case characteristics, and corroborating evidence The increase is clinically irrelevant because the reaction was already known

Question 9 of 10 When a PSUR supports a product-information change, what should the report demonstrate?

Only that the change has been proposed by the safety department A traceable relationship between the evidence, risk interpretation, benefit-risk consequence, proposed wording, and applicable regulatory pathway That a separate variation procedure must always be submitted first That the proposed wording is identical to the wording in another product's information

Question 10 of 10 Which statement reflects appropriate interpretation of a non-significant statistical result?

It proves that the product has no effect on the event It proves that the event is unrelated to treatment It should be interpreted in light of effect estimates, precision, study limitations, power, and clinical relevance It establishes that no further monitoring is needed

Knowledge Assessment: Writing the PSUR Safety Evaluation

Cookie Settings